Clarify the Role of Bijuva for Vasomotor Symptoms

June 2019

Bijuva (bye-JOO-vah, estradiol/progesterone) will compete with other hormone therapy (HT) options for hot flashes during menopause.

You'll hear that it's the first FDA-approved combo of "bioidentical" estrogen and progesterone in one oral capsule.

It's a fixed dose of estradiol 1 mg and progesterone 100 mg...similar to oral Estrace plus Prometrium. These are also "bioidenticals."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Opioids Start a Dialogue About Tapering Chronic Opioids
Gastroenterology Don't Think of Meds as a Significant Source of Gluten
Diabetes Weigh Pros and Cons of SGLT2 Inhibitors for Kidney Protection
Cannabinoids Be Prepared for Patients to Ask About CBD
Menopause Clarify the Role of Bijuva for Vasomotor Symptoms
HIV AIDS Expect to See Fewer Antibiotics for MAC Prophylaxis in Patients With HIV
Osteoporosis Advise Saving Evenity for High-Risk Women With Osteoporosis
Warts Tell Patients to Be Persistent When Treating Warts
Infectious Diseases Don't Advise Screening for UTIs in Most Patients Without Symptoms
Insomnia Explain Risk of Strange Sleep Behaviors With "Z-Drugs"